U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06921148) titled 'Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy' on March 28.
Brief Summary: This study will investigate the utility of Silk bioprotein, an FDA-approved and readily available post-surgical dressing, as a wound dressing for patients undergoing double-incision mastectomy for female-to-male gender affirmation surgery.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Wound Healing
Intervention:
PROCEDURE: One side of chest wall with Silk bioprotein dressing. Other side of chest wall with Dermabond/Prineo dressing
Patients will have Silk bioprotein post-surgical dressing on one side of chest wal...